June 5, 2013 — It is a violation of the federal False Claims Act for a drug manufacturer to distribute adulterated pharmaceuticals. Adulterated medications may not help the patients they are prescribed to treat, or worse, they may actually harm the patients. To combat the problem, the Department of Justice relies on whistleblowers and the federal False Claims Act. The qui tam language of...


